Cornerstone Advisors (Washington)’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Cornerstone Advisors (Washington)'s RMD Position: Q3 2020 in Review
Cornerstone Advisors (Washington) reduced its ResMed (RMD) stake by 1.9% in Q3 2020, selling an estimated $8.31K and leaving 2,326 shares worth $399K. The position accounts for 0.04% of the portfolio, ranked #56.
Cornerstone Advisors (Washington) first reported a position in RMD in Q4 2014 and has held it in 24 quarters since. The position peaked at $455K in Q2 2020. 627 funds tracked by Wall St. Rank hold RMD as of Q3 2020.
- Cornerstone Advisors (Washington) held 2,326 shares of ResMed worth $399K as of Q3 2020.
- Cornerstone Advisors (Washington) sold 45 ResMed shares in Q3 2020, an estimated $8.31K.
- ResMed made up 0.04% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #56 holding.
- Cornerstone Advisors (Washington) first reported a position in ResMed in Q4 2014 and has held it in 24 quarters since.
- Cornerstone Advisors (Washington)'s ResMed position peaked at $455K in Q2 2020.
- 627 funds tracked by Wall St. Rank held ResMed as of Q3 2020.
Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.